26
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Alterations in protein tyrosine kinase pathways following retinal vein occlusion in the rat

, &
Pages 231-239 | Published online: 02 Jul 2009

References

  • Michaelson, I. C. (1948) The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. iTrans. Ophthalmol. Soc. UKi b68,b 137–180.
  • Ashton, N. (1962) Neovascularization in ocular disease. iTrans. Ophthalmol. Soc. UKi b38,b 397–432.
  • Patz, A. (1982) Clinical and experimental studies on reti-nal neovascularization. iAm. J. Ophthalmol.i b94,b 715–743.
  • Sivalingam, A., Kenney, J., Brown, G. C., Benson, W. E., Donoso, L. (1990) Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic ret-inopathy. iArch. Ophthalmol.i b108,b 869–872.
  • Klagsbrun, M., D'Amore, P. A. (1991) Regulators of an-giogenesis. iAnnu. Rev. Physiol.i b53,b 217–239.
  • Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., Nguyen, H. V., Aiello, L.M., Ferrara, N., King, G. L. (1994) Vascular endothe-lial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. iN. Eng. J. Med.i b331,b 1480–1487.
  • Pe'er, J., Shweiki, D., Itin, A., Hemo, I., Gnessin, H., Keshet, E. (1995) Hypoxia-induced expression of vas-cular endothelial growth factor by retinal cells is a com-mon factor in neovascularizing ocular diseases. iLab. Invest.i b72,b 638–645.
  • Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., Berse, B., Yeo, T., Yeo, K. T. (1994) Vascular endothelial growth factor / vas-cular permeability factor is temporally and spatially cor-related with ocular angiogenesis in a primate model. iAm. J. Pathol.i b145,b 574–584.
  • Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., Smith, L. E. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using VEGF-receptor chimeric proteins. iProc. Natl. Acad. Sci. USA.i b92,b 10457–10461.
  • Adamis, A. P., Shima, D. T., Tolentino, M. J., Gragoudas, E. S., Ferrara, N., Folkman, J., D'Amore, P. A., Miller, J. W. (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovas-cularization in a nonhuman primate. iArch. Ophthalmol.i b114,b 66–71.
  • Aiello, L. P., Northrup, J. M., Keyt, B. A., Takagi, H., Iwamoto, M. A. (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. iArch. Oph-thalmol.i b113,b 1538–1544.
  • Dorey, C. K., Aouididi, S., Reynaud, X., Dvorak, H. F., Brown, L. F. (1996) Correlation of vascular permeabil-ity factor/ vascular endothelial growth factor with extraretinal neovascularization in the rat. iArch. Ophthalmol.i b114,b 1210–1217.
  • Pierce, E. A., Foley, E. D., Smith, L. E. H. (1996) Regu-lation of vascular endothelial grwoth factor by oxygen in a model of retinopathy of prematurity. iArch. Ophthalmol.i b114,b 1219–1228.
  • Schlingemann, R. 0., van Hinsbergh, V. W. M. (1997) Role of vascular permeability factor/ vascular endothe-lial growth factor in eye disease. iBr. J. Ophthalmol.i b81,b 501–512.
  • Pournaras, C. J., Miller, J. W., Gragoudas, E. S., Husain,D., Munoz, J. L., Tolentino, M. J., Kuroki, M., Adamis, A. P. (1997) Systemic hyperoxia decreases vascular en-dothelial growth factor gene expression in ischemic pri-mate retina. iArch. Ophthalmol.i b115,b 1553–1558.
  • Pe'er, J., Folberg, R., Itin, A., Gnessin, H., Hemo, I., Keshet, E. (1998) Vascular endothelial growth factor upregulation in human central retinal vein occlusion. iOph-thalmology,i b105,b 412–416.
  • Schlessinger, J., Ullrich, A. (1992) Growth factor sig-naling by receptor tyrosine kinases. iNeuron,i b9,b 383–391.
  • Kazlauskas, A. (1994) Receptor tyrosine kinases and their targets. iCurr. Opin. Genet. Dev.i b4,b 5–14.
  • Guo, D., Jia, Q., Song, H. Y., Warren, R. S., Donner, D. B. (1995) Vascular endothelial cell growth factor pro-motes tyrosine phosphorylation of mediators of signal transduction that contain 5H2 domains. iJ. Biol. Chem.i b270,b 6729–6733.
  • D'Angelo, G., Struman, I., Martial, J., Weiner, R. I. (1995) Activation of mitogen-activated protein kinases by vas-cular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. iProc. Natl. Acad. Sci. USA,i b92,b 6374–6378.
  • Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., King, G. L. (1995) Characterization of vascular endothelial growth factors effect on the activation of pro-tein kinase C, its isoforms, and endothelial cell growth. iJ. Clin. Invest.i b98,b 2018–2026.
  • Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F. (1997) Vascular per-meability factor/ vascular endothelial growth factor: a mutifunctional angiogenic cytokine. iEXS.i b79,b 233–269.
  • Kroll, J., Waltenberger, J. (1997) The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells.iJBiol. Chem.i b272,b 32521–32527.
  • Davis, R. J. (1993) The mitogen-activated protein kinase signal transduction pathway. iJ. Biol. Chem.i b268,b 14553–14556.
  • de Juan, E. Jr, Stefansson E, Ohira A. (1990) Basic fi-broblast growth factor stimulates 3H-thymidine uptake in retinal venular and capillary endothelial cells in vivo. iInvest. Ophthalmol. Vis. Sci.i b31,b 238–1244.
  • de Juan, E. Jr, Stefansson E, Dickson J. (1990) Capil-lary endothelial cell mitogenic activity in experimental branch vein occlusion. iGraefe's Arch. Clin. Exp. Ophthalmol.i b228,b 191–194.
  • Koroma, B. M., de Juan, E. Jr. (1994) Phosphotyrosine inhibition and control of vascular endothelial cell pro-liferation by genistein. iBiochem. Pharmacol.i b48,b 809–818.
  • Koroma, B. M., de Juan, E. Jr. (1995) Changes associ-ated with tyrosine phosphorylation during short-term hy-poxia in retinal microvascular endothelial cells in vitro. iJ. Cell Biochem.i b59,b 123–132.
  • Hayashi, A., Koroma, B. M., Imai, K., de Juan, E. Jr. (1996) Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury. iInvest. Ophthalmol. Vis. Sci.i b37,b 2146–2156.
  • Hayashi, A., Imai, K., Kim, H. C., de Juan, E. Jr. (1997) Activation of protein tyrosine phosphorylation after retinal branch vein occlusion in cats. iInvest. Ophthalmol. Vis. Sci.i b38,b 372–380.
  • Michels, R. G., Gass, J. D. M. (1974) The natural course of retinal branch vein obstruction. iTrans. Am. Acad.iDelayed neuronal death in ischemic hippocampus involves stimulation of protein tyrosine phosphorylation. iAm. J. Physiol.i b271,b C1085-C1097.iOphthalmol. Otolaryngol.i b78,b OP166–177.
  • Orth, D. H., Patz, A. (1978) Retinal branch vein occlu-sion. iSurv. Ophthalmol.i b22,b 357–376.
  • Ruff-Jamison, S., Campos-Gonazalez, R., Glenney, Jr., JR. (1991) Heavy and light chain variable region se-quences and antibody properties of anti-phosphotyrosine antibodies reveal both common and distinct features. iJ. Biol. Chem.i b266,b 6607–6613.
  • Campochiaro, P. A., Hackett, S. F., Vinores, S. A., Freund, J., Csaky, C., LaRochelle, W., Henderer, J., Johnson, M., Rodriguez, I. R., Friedman, Z., Derevjanik, N., Dooner, J. (1994) Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epi-thelial cells. iJ. Cell Sci.i b107,b 2459–2469.
  • Danis, R. P., Wallow, I. H. L. (1987) Microvascular changes in experimental branch retinal vein occlusion. iOphthalmology,i b94,b 1213–1221.
  • Ballaun, C., Weninger, W., Uthman, A., Weich, H., Tschachler, E. (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. iJ. Invest. Dermatol.i b104,b 7–10.
  • Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., Ferrara, N. (1996) The car-boxyl-terminal domain (111-165) of vascular endothe-lial growth factor is critical for its mitogenic potency. iJ. Biol. Chem.i b271,b 7788–7795.
  • Presta, M., Foiani, M., Rusnati, M., Silverstein, J. J., Maier, J. A., Ragnotti, G. (1988) High molecular weight immunoreactive basic fibroblast growth factor-like pro-teins in rat pituitary and brain. iNeurosci. Lett.i b90,b 308–313.
  • Powell, P. P., Klagsbrun, M. (1991) Three forms of rat basic fibroblast growth factor are made a single mRNA and localize to the nucleus. iJ. Cell Physiol.i b148,b 202–210.
  • Klagsbrun, M., Smith, S., Sullivan, R., Shing, Y., Davidson, S., Smith, J. A., Sasse, J. (1987) Multiple forms of basic fibroblast growth factor: amino-terminal cleav-ages by tumor cell-and brain cell-derived acid protein-ases. iProc. Natl. Acad. Sci. USA.i b84,b 1839–1843.
  • Frank, L., Bruhn, T., Diemer, N. H. (1993) The effect of an AMPA antagonist (NBQX) on postischemic neu-ron loss and protein synthesis in the rat brain. iExp. Brain. Res.i b95,b 70–76.
  • Widmann, R., Miyazawa, T., Hossmann, K. A. (1993) Protective effect of hypothermia on hippocampal injury after 30 minutes of forebrain ischemia in rats is medi-ated by postischemic recovery of protein synthesis. iJ. Neurochem.i b61,b 200–209.
  • Hayashi, A., Weinberger, A. W. A., Kim, H. C., de Juan, E. Jr. (1997) Genistein, a protein tyrosine kinase inhibi-tor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. iInvest. Ophthalmol. Vis. Sci.i b38,b 1193–1202.
  • Ohtsuki, T., Matsumoto, M., Kitagawa, K., Mabuchi, T., Mandai, K., Matsushita, K., Kuwabara, K., Tagawa, M., Ogawa, S., Ueda, H., Kamada, T., Yanagihara, T. (1996)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.